Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.
Rivero-Ferrer E, Olesen M, Plana E, Aguado J, Saigí-Morgui N, Rubino A, Daoud SZ, Lei A, Perez-Gutthann S, Schink T, Kristiansen NS, Hallas J, Pottegård A, Rebordosa C. Rivero-Ferrer E, et al. Among authors: plana e. Clin Drug Investig. 2022 Apr;42(4):319-331. doi: 10.1007/s40261-022-01120-2. Epub 2022 Mar 15. Clin Drug Investig. 2022. PMID: 35290649 Free PMC article.
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.
Rebordosa C, Plana E, Rubino A, Aguado J, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E. Rebordosa C, et al. Among authors: plana e. Int J Chron Obstruct Pulmon Dis. 2021 May 31;16:1461-1475. doi: 10.2147/COPD.S301624. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34103906 Free PMC article.
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.
Rebordosa C, Plana E, Rubino A, Aguado J, Martinez D, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E. Rebordosa C, et al. Among authors: plana e. Int J Chron Obstruct Pulmon Dis. 2022 Aug 2;17:1715-1733. doi: 10.2147/COPD.S363997. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35941901 Free PMC article.
Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe.
Cainzos-Achirica M, Varas-Lorenzo C, Pottegård A, Asmar J, Plana E, Rasmussen L, Bizouard G, Forns J, Hellfritzsch M, Zint K, Perez-Gutthann S, Pladevall-Vila M. Cainzos-Achirica M, et al. Among authors: plana e. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):713-723. doi: 10.1002/pds.4416. Epub 2018 Mar 23. Pharmacoepidemiol Drug Saf. 2018. PMID: 29570897
Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases.
Cainzos-Achirica M, Rebordosa C, Vela E, Cleries M, Matsushita K, Plana E, Rivero-Ferrer E, Enjuanes C, Jimenez-Marrero S, Garcia-Rodriguez LA, Comin-Colet J, Perez-Gutthann S. Cainzos-Achirica M, et al. Among authors: plana e. Am Heart J. 2018 Aug;202:76-83. doi: 10.1016/j.ahj.2018.05.005. Epub 2018 May 21. Am Heart J. 2018. PMID: 29902694 Review.
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study.
Forns J, Dudukina E, Hägg D, Szentkúti P, Gembert K, Plana E, Gilsenan A, Horváth-Puhó E, Ehrenstein V, Reutfors J, Rebordosa C. Forns J, et al. Among authors: plana e. Neurol Ther. 2022 Dec;11(4):1659-1676. doi: 10.1007/s40120-022-00396-y. Epub 2022 Aug 26. Neurol Ther. 2022. PMID: 36028603 Free PMC article.
92 results